These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 412700
1. The influence of anti-theta-globulin treatment on the growth of mastocytoma in mice. Syrjänen KJ, Hjelt LH. Exp Pathol (Jena); 1977; 14(3-4):208-14. PubMed ID: 412700 [Abstract] [Full Text] [Related]
2. Histologic changes in mouse lymph nodes after treatment with antitheta-globulin. Syrjänen KJ. Exp Pathol (Jena); 1977; 14(3-4):171-9. PubMed ID: 304016 [Abstract] [Full Text] [Related]
3. The effects of anti-theta-globulin treatment on the morphology of the mouse spleen. Syrjänen KJ. Exp Pathol (Jena); 1978; 15(1):38-45. PubMed ID: 305853 [Abstract] [Full Text] [Related]
4. Experimental cancer immunotherapy in DBA/2 mouse-mastocytoma model utilizing autologous tumor tissue polymerised with ethylchlorformiate. Soimakallio S, Syrjänen KJ. Exp Pathol (Jena); 1980; 18(6):346-52. PubMed ID: 6774879 [Abstract] [Full Text] [Related]
5. Post-capillary venules in the lymphatic tissues of mice bearing experimental neoplasia. Syrjänen KJ. Exp Pathol (Jena); 1978; 15(6):348-54. PubMed ID: 105923 [Abstract] [Full Text] [Related]
6. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. III. Morphometric assessment of the dynamic changes in post-capillary venules as regulatory elements of lymphocyte recirculation in tumor-draining lymph nodes. Tosi P, Syrjänen K, Cintorino M, Mäntyjärvi R, Luzi P, Miracco C, Laatikainen A, Leoncini L, Santopietro R. Arch Geschwulstforsch; 1987; 57(1):7-15. PubMed ID: 3105513 [Abstract] [Full Text] [Related]
7. Suppressor cells in the spleen of tumor-allosensitized mice. Argyris BF. Cancer Res; 1977 Sep; 37(9):3390-9. PubMed ID: 141979 [Abstract] [Full Text] [Related]
8. Activation of suppressor cells by syngeneic tumor transplants in mice. Argyris BF. Cancer Res; 1978 May; 38(5):1269-73. PubMed ID: 147732 [Abstract] [Full Text] [Related]
12. Specificity and immunosuppressive potency of a rabbit antimouse T cell-specific antiserum. Ochiai T, Ahmed A, Strong DM, Scher I, Sell KW. Transplantation; 1975 Sep; 20(3):198-210. PubMed ID: 1099727 [Abstract] [Full Text] [Related]
13. Endothelium-associated IgG in the post-capillary venules of the lymphatic tissues in mice bearing experimental neoplasia. Syrjänen KJ. Exp Pathol (Jena); 1979 Sep; 17(5):264-70. PubMed ID: 113244 [Abstract] [Full Text] [Related]
14. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice. Germain RN, Williams RM, Benacerraf B. Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167 [Abstract] [Full Text] [Related]
15. BCG immunopotentiation of an antitumor response: evidence for a cell-mediated mechanism. Hawrylko E. J Natl Cancer Inst; 1975 Aug; 55(2):413-23. PubMed ID: 808641 [Abstract] [Full Text] [Related]
16. In vitro stimulation and inhibition of tumor cell growth mediated by different lymphoid cell populations. Norbury KC. Cancer Res; 1977 May; 37(5):1408-15. PubMed ID: 66982 [Abstract] [Full Text] [Related]
17. Potentiation of cytotoxic T-cell function by virus. Reinisch CL, Schlossman SF. J Natl Cancer Inst; 1976 Dec; 57(6):1277-81. PubMed ID: 63565 [Abstract] [Full Text] [Related]
18. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. II. Morphometric assessment of immunoreactivity in the thymus and spleen related to lymphocyte subsets in peripheral blood. Syrjänen K, Tosi P, Cintorino M, Mäntyjärvi R, Luzi P, Leoncini L, Laatikainen A, Miracco C, Santopietro R. Exp Pathol; 1986 Dec; 30(2):75-82. PubMed ID: 3096774 [Abstract] [Full Text] [Related]